Early diagnosis is essential in the management of the complicated diseases. Starting from the serum biomarkers, invasive procedures revealed a number of biological molecules have been tried and tested for the suitability in early diagnosis. This article discusses a new noninvasive device for early disease detection. The researchers in Israel have developed a device that helps in non-invasive early diagnosis of pathological conditions by detecting and analyzing molecules released through exhalation.
The device had undergone trials that included a pool of 1,404 healthy and sick people across five countries. Rationale: At the onset of pathological symptoms, such as in cancer, the affected cells release specific varieties volatile organic compounds (VOC) in the extracellular space. However, the concentrations of these VOCs are extremely less. Alternatively, in disease conditions, the levels…
